openPR Logo
Press release

Preimplantation Genetic Diagnosis Market to Reach an Opportunity of US$118.0 Mn by the End of 2020

09-06-2018 11:25 AM CET | Health & Medicine

Press release from: Transparency Market Research

Transparency Market Research

Transparency Market Research

Preimplantation genetic diagnosis (PGD) is an adjuvant technique to in vitro fertilization (IVF) for detecting genetic diseases or conditions before the implantation of embryo. PGD can be performed for screening of a range of medical conditions such as Down’s syndrome, inheritable diseases and traits of other physiological abnormality. Increasing patient awareness about PGD technique and rising prevalence of genetic disorders among infants has led to the rise in demand for PGD along with IVF procedure. The combination of PGD and IVF has improved the rate of successful pregnancy due to reduced chances of passing the undesired genetic material in the embryo.

Report Overview @

The use of array comparative genomic hybridization (aCGH) and fluorescent in situ hybridization (FISH) techniques in PGD has improved the process efficiency and success rate of pregnancy through IVF. Demand for PGD, however, is dependent on the regulations governing infertility procedures in various countries. PGD for gender selection and HLA typing is banned in most parts of Asia, whereas it is regulated in the U.S. and in some parts of the European Union. Regulatory impact plays a major role in analyzing the global preimplantation genetic diagnosis market.

Based on the type of test, the global preimplantation genetic diagnosis market has been categorized into six segments: PGD for chromosomal aberrations, PGD for aneuploidy screening, PGD for gender selection, PGD for single gene disorder, PDG for HLA typing and PGD for X-linked diseases. PGD for aneuploidy screening held the highest share in 2013 as aneuploidy could lead to severe abnormalities. Aneuploidy screening reduces the probability of transferring an embryo with chromosomal abnormality. . Aneuploidy screening during prenatal testing has a major disadvantage; if the chromosomal abnormality were detected in the fetus, the pregnancy would be terminated. However, this drawback is efficiently overcome by opting for preimplantation genetic diagnosis, since genetic screening for aneuploidy is performed before the embryo is implanted and pregnancy is conceived.

Request A Sample Copy @

Geographically, the global preimplantation genetic diagnosis market has been categorized into four regions: North America, Europe, Asia Pacific and Rest of the World (RoW). Each geographical market has been further analyzed based on the types of test. Europe dominated the global preimplantation genetic diagnosis market in 2013 due to increasing patient awareness and high number of IVF cycles being performed in the region. Conversely, North America is expected to grow at a higher CAGR during the forecast period due to rapid increase in the number of IVF cycles being performed and the rising disability rate due to increase in smoking. Moreover, high cost of the gender selection procedure and rising demand for identifying and selecting the gender by mothers increases the market share of PGD in gender selection. Restrictions on gender selection and detection of X-linked diseases in developing regions such as Asia Pacific, Latin America and Africa restrain the growth of the PGD market. Moreover, lack of patient awareness and inadequate healthcare facilities in the developing economies of these regions limit the use of PGD in HLA typing and detection of single gene disorder.

Request Brochure @

The global preimplantation genetic diagnosis market is characterized by the presence of some of the major companies including Genesis Genetics, Genea Ltd., Illumina, Inc., Laboratory Corporation of America Holdings, Natera, Inc., PerkinElmer, Inc., Quest Diagnostics, Inc., Reprogenetics LLC and Reproductive Genetics Institute. Market players are in constant endeavor to improve their technologies in genetic testing in order to enhance the efficiency and provide better services to healthcare practitioners.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

Contact Us

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Preimplantation Genetic Diagnosis Market to Reach an Opportunity of US$118.0 Mn by the End of 2020 here

News-ID: 1223815 • Views: 155

More Releases from Transparency Market Research

Endoscopy Repair MarketSet for Rapid Growth and Trend, by 2025
Global Endoscope Repair Market: Overview An endoscope is an instrument used to view any internal cavity of the human body. Endoscopes are inserted into the body via one of many natural orifices. A high resolution camera at the end of inert tubing allows visualization of the body from inside and makes clinical decision making easier. Endoscopes are made of inert material like polyurethane which resists corrosion from bodily fluids and is
Nasal Oxygen Cannula Marketto Set Phenomenal Growth by 2026
Global Nasal Oxygen Cannula Market: Overview A cannula is any tube inserted into the body. A nasal cannula is an oxygen conduit used to deliver high concentrations of oxygen to patients through the nose. Traditionally made of rubber, current versions are made of plastic and can be connected to any oxygen supply by a pliable universal connector. This allows easy adaptability of this product to any setting, for in patient or
Medically Supervised Weight Loss Service MarketShares, Strategies, and Forecasts …
Global Medically Supervised Weight Loss Service Market: Overview Obesity has reached concerning levels around the world, with an increasing number of people tipping the scales. 69% of Americans are estimated to be overweight or obese at this point in time. Excess weight is increasingly linked with a number of chronic diseases that figure as the top causes of mortality worldwide. Also, popular human aesthetics are pushing people towards a fitter body
Bone Conduction Hearing Devices Market: Business Overview and Global Development …
Global Bone Conduction Hearing Devices Market: Snapshot Growing instances of hearing issues among older population is working as a driving factor for the growth of the global bone conduction hearing devices market. Bone conduction hearing devices are gaining popularity in all worldwide populace owing to their ability to work as a substitute to conventional hearing devices. These devices are used by people who are suffering from hearing issues related to miss

All 5 Releases

More Releases for PGD

Global Preimplantation Genetics Diagnosis (PGD) Market Analysis Report 2019 by S …
Preimplantation genetic diagnosis (PGD) also referred to as embryo screening, is a branch of genetics involves in genetic testing of the embryo through In-Vitro Fertilization (IVF). PGD eliminates the risk of selective pregnancy termination for couples who are at substantial risk of transferring serious genetic, chromosomal or hereditary disorders such as spinal muscular atrophy and cystic fibrosis. Get the sample report: Preimplantation Genetic Diagnosis Market Report, published by Allied Market Research,
Latest Research on Preimplantation Genetics Diagnosis (PGD) Market 2018 Global A …
The latest report published on Up Market Research, on Preimplantation Genetics Diagnosis (PGD) Market Analysis offers comprehensive analysis, delivering detailed market data and penetrating insights. The report covers detailed Preimplantation Genetics Diagnosis (PGD) Market analysis by Product, Application, Region, Major Player, Market Size, Share, Trends, Growth and Forecast 2018-2025. Get Free Sample Copy Of This Report @ The Preimplantation Genetics Diagnosis (PGD) Market report published on Up Market Research is spread
Global Preimplantation Genetics Diagnosis (PGD)s Market Research, Size, Share An …
The global market size of Preimplantation Genetics Diagnosis (PGD) is $XX million in 2017 with XX CAGR from 2013 to 2017, and it is expected to reach $XX million by the end of 2023 with a CAGR of XX% from 2018 to 2023. There are 3 key segments covered in this report: geography segment, end use/application segment and competitor segment. Get Free Sample Report at
Global Preimplantation Genetic Diagnosis (PGD) Market is Anticipated to Reach US …
A new Transparency Market Research report states that the global preimplantation genetic diagnosis (PGD) market stood at US$77.2 mn in 2013 and is anticipated to reach US$118 mn by 2020, by expanding at a CAGR of 6.28% from 2014 to 2020. The title of the report is “Preimplantation Genetic Diagnosis Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020.” Preimplantation genetic diagnosis (PGD) is the genetic
Global Preimplantation Genetic Diagnosis Market (PGD) to Reach $121.50 Million b …
Market Research Reports Search Engine (MRRSE) has been serving as an active source to cater intelligent research report to enlighten both readers and investors. This research study titled “Preimplantation Genetic Diagnosis Market “ Get Free Sample Report @ Since the last two decades, preimplantation genetic diagnosis (PGD) has been used to detect chromosomal aneuploidy in low prognosis patients who undergo in-vitro fertilization (IVF). PGD is now being used to detect a broader
Preimplantation Genetic Diagnosis Market : Asia PGD Market To Witness Highest Tr …
Rising numbers of assisted reproductive procedures such as in vitro fertilization (IVF) is Asia is the most prominent factor driving the market for preimplantation genetic diagnosis. This is, in essence, the result of factors such as the delayed age of conception among Asian women, the rising rate of infertility among the population, and the significantly expanding medical tourism industry in the region. Rising disposable incomes and increased awareness regarding the